Chronic obstructive pulmonary disease (COPD) is a global health problem, and since 2001,
the Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published its strategy …

Chronic obstructive pulmonary disease (COPD) is the third most common cause of death in
the USA. In 2010, the cost of COPD in the USA was projected to be approximately US …

Background Estimation suggests that at least 4 million people die, annually, as a result of
chronic respiratory disease (CRD). The Global Alliance against Chronic Respiratory …

The French social philosopher Pierre Bourdieu is now recognised as one of the major
thinkers of the twentieth century. In a career of over fifty years, Bourdieu studied a wide …

Background Chronic obstructive pulmonary disease (COPD) is characterized by an
incompletely reversible limitation in airflow. A physiological variable—the forced expiratory …

Background The Standards for the Diagnosis and Treatment of Patients with COPD
document 2004 updates the position papers on chronic obstructive pulmonary disease …

Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of
morbidity, mortality, and resource use worldwide. The goal of this Official American Thoracic …

COPD is one of the leading causes of morbidity and mortality worldwide and imparts a
substantial economic burden on individuals and society. Despite the intense interest in …

The FEV1 is widely used by physicians in the diagnosis, staging, treatment, monitoring and
establishing prognosis for patients with COPD. The MCID is the smallest difference which …

Tiotropium, a novel once-daily inhaled anticholinergic, has been shown to improve lung
function over a 24-h period. In order to extend these findings, health-outcomes were …